ArticlePharmaceuticals (Basel, Switzerland)2021

P-Glycoprotein (ABCB1/MDR1) and BCRP (ABCG2) Limit Brain Accumulation and Cytochrome P450-3A (CYP3A) Restricts Oral Exposure of the RET Inhibitor Selpercatinib (RETEVMO).

Yaogeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.